ATLASPMV Pharmaceuticals (PMVP) earnings date: Nov 11, 2026
PMV Pharmaceuticals (PMVP) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 11, 2026. Analysts expect EPS of -$0.31.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on PMVP
| Last price | $1.36 (+3.8%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.5% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 3 reports |
These figures come from the same calibrated model and valuation as the PMV Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
PMV Pharmaceuticals reports on Nov 11, 2026. One email the day before, with ATLAS’s read on PMV Pharmaceuticals. You can switch it off at any time.
Alert me before PMVP reportsFree to start. Creating an account takes under a minute.
Notify me when PMV Pharmaceuticals reports
Track PMVP free Add PMV Pharmaceuticals to a free ATLAS watchlist and see its next report date in one place.
PMVP earnings at a glance
| Next report (confirmed) | Wed, Nov 11, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.31 |
| Last report | Aug 14, 2026 · Beat |
| Beat rate (last 3 reports) | 3 of 3 (100%) |
| Average EPS surprise | +13.2% |
| Average move around a report | ±2.6% (last 3) |
| Sector | Healthcare · Biotechnology |
PMV Pharmaceuticals earnings history: last 3 reports
PMV Pharmaceuticals last reported on Aug 14, 2026: EPS of -$0.34 against an estimate of -$0.40 (+15.0% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 14, 2026 | -$0.40 | -$0.34 | +15.0% | Beat | +2.9% |
| Jul 29, 2026 | $1.19 | $1.35 | +13.5% | Beat | +2.7% |
| Apr 29, 2026 | $3.69 | $4.10 | +11.1% | Beat | -2.1% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for PMVP
See the fair value, the probability range and the earnings history of PMV Pharmaceuticals on its ATLAS page.
PMV Pharmaceuticals (PMVP) stock analysisPlans from €3.99 a month.
PMV Pharmaceuticals earnings: frequently asked questions
When does PMV Pharmaceuticals (PMVP) report earnings?
PMV Pharmaceuticals is scheduled to report on Wednesday, November 11, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for PMVP?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.31 per share (USD). Estimates can change before the report.
How often does PMVP beat earnings estimates?
Of its last 3 reports with a recorded result, PMV Pharmaceuticals beat the EPS estimate 3 times; the average surprise was +13.2%. Past results do not predict the next one.
How much does PMVP move around earnings?
Over its last 3 reports the stock moved an average of 2.6% (absolute, from the close before the report day to the close after it), and finished higher 2 of 3 times.
Did PMV Pharmaceuticals beat earnings estimates last quarter?
PMV Pharmaceuticals last reported on Aug 14, 2026: EPS of -$0.34 against an estimate of -$0.40 (+15.0% surprise), a beat.
How much does PMVP usually move in a day?
On a normal trading day the ATLAS model puts PMVP’s one-day range at about ±5.5%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 11, 2026
Educational information, not investment advice. Disclaimer